Advanced Eyecare, Llc Optometrist Medicare: Medicare Enrolled Practice Location: 5 Alex Pl, Picayune, MS 39466 Phone: 601-799-0707 Fax: 601-799-0700 |
Dr. Johneen Gilich, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 235 Frontage Rd, Picayune, MS 39466 Phone: 228-861-6989 Fax: 601-799-4685 |
Lori L Blackmer, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 908 Sixth Ave, Picayune, MS 39466 Phone: 601-798-4182 Fax: 601-798-4770 |
Dr. Kraig Michael Stasney, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 718 Highway 11 S Ste B, Picayune, MS 39466 Phone: 601-799-0707 Fax: 601-799-0700 |
Picayune Eye Clinic Optometrist Medicare: Medicare Enrolled Practice Location: 908 Sixth Ave, Picayune, MS 39466 Phone: 601-798-4182 Fax: 601-798-4770 |
News Archive
UK scientists have cracked one of the key biological processes used by viruses such as HIV and SARS when they replicate according to a paper published in the journal Nature tomorrow (11 May). Viruses are able to interfere with the host cell processes that our bodies use to replicate cells, and protein synthesis is often one of their targets.
A new study from India, currently available on the preprint server bioRxiv*, estimated the probability and readiness of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to infect cells of different animal species – and revealed many of them that could act as disease carriers.
Quick-Med Technologies, Inc. announced today that the Food and Drug Administration has issued Guidance to support the classification of the Company's NIMBUS® barrier gauze wound dressings as Class II medical devices.
SYSPRO, the leading provider of visionary, pragmatic ERP software, today announced that Reese Pharmaceutical Company has selected SYSPRO ERP (Enterprise Resource Planning) software to run its private labeling and distribution operations. Reese, based in Cleveland, Ohio, has been in business for more than a century.
The U.S. Food and Drug Administration's (FDA) Office of Criminal Investigations (OCI) has announced that The Purdue Frederick Company, Inc. has agreed to pay more than $700 million to resolve criminal charges and civil liabilities in connection with several illegal schemes to promote, market and sell OxyContin, a powerful prescription pain reliever that the company produces.
› Verified 5 days ago